Hempel M, Hinkelbein W
Department of Radiotherapy, University Hospital, Freiburg, Fed. Rep. of Germany.
Recent Results Cancer Res. 1993;130:231-6. doi: 10.1007/978-3-642-84892-6_20.
The early reactions of the eye to radiation are conjunctivitis and, with higher doses, corneal damage. The inflammatory reactions are transient and remit within a few weeks after the end of radiotherapy. Doses above 60 Gy can produce corneal ulcerations with the risk of perforation and loss of the eye. The most frequent late reaction of the eye is cataract of the lens. The tolerance dose (about 5 Gy) is extremely low and the latent period varies from 6 months to 3 years. The lens in children has a much lower tolerance. The increasing potential for optical support and ophthalmic surgery over recent decades has reduced the fear of this complication. The most severe late complications are retinopathy (RR) and neuropathy of the optic nerve (RON), both of which are caused by radiation-induced microangiopathy. Visual loss is very frequent and complete blindness is seen with high doses in the range of 50-60 Gy. The latent period of these injuries varies widely from 1 month to 15 years, but they usually occur within 3 years of treatment. Conflicting frequencies are reported in the literature. Beyond 30 Gy, usually no RR is seen. However, the lowest recorded dose producing RR is 11 Gy. In the high dose range of 60-70 Gy RR and RON are found in 10%-100% of patients. There is a great need for prospective trials to estimate the true risk to patients with nasopharyngeal, maxillo-ethmoidal, and orbital tumors, pituitary adenomas, and tumors of the salivary glands. To minimize complications of radiotherapy to the eyes daily fractions should be reduced to 1.7-1.8Gy.(ABSTRACT TRUNCATED AT 250 WORDS)
眼睛对辐射的早期反应是结膜炎,剂量较高时会出现角膜损伤。炎症反应是短暂的,放疗结束后几周内会消退。剂量超过60 Gy可导致角膜溃疡,有穿孔和失明的风险。眼睛最常见的晚期反应是晶状体白内障。耐受剂量(约5 Gy)极低,潜伏期从6个月到3年不等。儿童晶状体的耐受性要低得多。近几十年来,光学支持和眼科手术的潜力不断增加,减少了对这种并发症的恐惧。最严重的晚期并发症是视网膜病变(RR)和视神经病变(RON),两者均由辐射诱导的微血管病变引起。视力丧失非常常见,50 - 60 Gy范围内的高剂量会导致完全失明。这些损伤的潜伏期差异很大,从1个月到15年不等,但通常在治疗后3年内发生。文献报道的发生率相互矛盾。超过30 Gy通常不会出现RR。然而,记录到的导致RR的最低剂量是11 Gy。在60 - 70 Gy的高剂量范围内,10% - 100%的患者会出现RR和RON。非常需要进行前瞻性试验,以评估鼻咽癌、上颌筛窦和眼眶肿瘤、垂体腺瘤以及唾液腺肿瘤患者的真正风险。为了尽量减少眼部放疗的并发症,每日分次剂量应减至1.7 - 1.8 Gy。(摘要截短于250字)